INTRODUCTION: The tobacco-specific nitrosamines (TSNAs) are an important group of carcinogens found in tobacco and tobacco smoke. To describe and characterize the levels of TSNAs in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014), we present four biomarkers of TSNA exposure: N'-nitrosonornicotine, N'-nitrosoanabasine, N'-nitrosoanatabine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) which is the primary urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. METHODS: We measured total TSNAs in 11 522 adults who provided urine using automated solid-phase extraction coupled to isotope dilution liquid chromatography-tandem mass spectrometry. After exclusions in this current analysis, we selected 11 004 NNAL results, 10 753 N'-nitrosonornicotine results, 10 919 N'-nitrosoanatabine results, and 10 996 N'-nitrosoanabasine results for data analysis. Geometric means and correlations were calculated using SAS and SUDAAN. RESULTS: TSNA concentrations were associated with choice of tobacco product and frequency of use. Among established, every day, exclusive tobacco product users, the geometric mean urinary NNAL concentration was highest for smokeless tobacco users (993.3; 95% confidence interval [CI: 839.2, 1147.3] ng/g creatinine), followed by all types of combustible tobacco product users (285.4; 95% CI: [267.9, 303.0] ng/g creatinine), poly tobacco users (278.6; 95% CI: [254.9, 302.2] ng/g creatinine), and e-cigarette product users (6.3; 95% CI: [4.7, 7.9] ng/g creatinine). TSNA concentrations were higher in every day users than in intermittent users for all the tobacco product groups. Among single product users, exposure to TSNAs differed by sex, age, race/ethnicity, and education. Urinary TSNAs and nicotine metabolite biomarkers were also highly correlated. CONCLUSIONS: We have provided PATH Study estimates of TSNA exposure among US adult users of a variety of tobacco products. These data can inform future tobacco product and human exposure evaluations and related regulatory activities. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2020.
INTRODUCTION: The tobacco-specific nitrosamines (TSNAs) are an important group of carcinogens found in tobacco and tobacco smoke. To describe and characterize the levels of TSNAs in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014), we present four biomarkers of TSNA exposure: N'-nitrosonornicotine, N'-nitrosoanabasine, N'-nitrosoanatabine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) which is the primary urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. METHODS: We measured total TSNAs in 11 522 adults who provided urine using automated solid-phase extraction coupled to isotope dilution liquid chromatography-tandem mass spectrometry. After exclusions in this current analysis, we selected 11 004 NNAL results, 10 753 N'-nitrosonornicotine results, 10 919 N'-nitrosoanatabine results, and 10 996 N'-nitrosoanabasine results for data analysis. Geometric means and correlations were calculated using SAS and SUDAAN. RESULTS: TSNA concentrations were associated with choice of tobacco product and frequency of use. Among established, every day, exclusive tobacco product users, the geometric mean urinary NNAL concentration was highest for smokeless tobacco users (993.3; 95% confidence interval [CI: 839.2, 1147.3] ng/g creatinine), followed by all types of combustible tobacco product users (285.4; 95% CI: [267.9, 303.0] ng/g creatinine), polytobacco users (278.6; 95% CI: [254.9, 302.2] ng/g creatinine), and e-cigarette product users (6.3; 95% CI: [4.7, 7.9] ng/g creatinine). TSNA concentrations were higher in every day users than in intermittent users for all the tobacco product groups. Among single product users, exposure to TSNAs differed by sex, age, race/ethnicity, and education. Urinary TSNAs and nicotine metabolite biomarkers were also highly correlated. CONCLUSIONS: We have provided PATH Study estimates of TSNA exposure among US adult users of a variety of tobacco products. These data can inform future tobacco product and human exposure evaluations and related regulatory activities. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2020.
Authors: Blair N Coleman; Brian Rostron; Sarah E Johnson; Bridget K Ambrose; Jennifer Pearson; Cassandra A Stanton; Baoguang Wang; Cristine Delnevo; Maansi Bansal-Travers; Heather L Kimmel; Maciej L Goniewicz; Raymond Niaura; David Abrams; Kevin P Conway; Nicolette Borek; Wilson M Compton; Andrew Hyland Journal: Tob Control Date: 2017-06-17 Impact factor: 7.552
Authors: Yan S Ding; Patricia Richter; Bryan Hearn; Liqin Zhang; Roberto Bravo; Xizheng Yan; Jose J Perez; Michele Chan; Jared Hughes; Patrick Chen; Wayne Chen; Joshua Wong; Sydney Holmberg; Shakia Smith; Morgan Larango; Liza Valentín-Blasini; Clifford H Watson Journal: Tob Regul Sci Date: 2017-01-01
Authors: Bryan A Hearn; Caroline C Renner; Yan S Ding; Christina Vaughan-Watson; Stephen B Stanfill; Liqin Zhang; Gregory M Polzin; David L Ashley; Clifford H Watson Journal: Nicotine Tob Res Date: 2013-01-03 Impact factor: 4.244
Authors: Lion Shahab; Maciej L Goniewicz; Benjamin C Blount; Jamie Brown; Ann McNeill; K Udeni Alwis; June Feng; Lanqing Wang; Robert West Journal: Ann Intern Med Date: 2017-02-07 Impact factor: 25.391
Authors: Maciej L Goniewicz; Danielle M Smith; Kathryn C Edwards; Benjamin C Blount; Kathleen L Caldwell; Jun Feng; Lanqing Wang; Carol Christensen; Bridget Ambrose; Nicolette Borek; Dana van Bemmel; Karen Konkel; Gladys Erives; Cassandra A Stanton; Elizabeth Lambert; Heather L Kimmel; Dorothy Hatsukami; Stephen S Hecht; Raymond S Niaura; Mark Travers; Charles Lawrence; Andrew J Hyland Journal: JAMA Netw Open Date: 2018-12-07
Authors: E Melinda Mahabee-Gittens; Georg E Matt; Lili Ding; Ashley L Merianos Journal: Int J Environ Res Public Health Date: 2021-11-10 Impact factor: 3.390
Authors: Pavel N Lizhnyak; Brendan Noggle; Lai Wei; Jeffery Edmiston; Elizabeth Becker; Ryan A Black; Mohamadi Sarkar Journal: Harm Reduct J Date: 2022-08-17
Authors: Rebecca J Evans-Polce; Danielle M Smith; Philip Veliz; Carol J Boyd; Sean Esteban McCabe Journal: Cancer Epidemiol Date: 2021-07-08 Impact factor: 2.890